Showing results (31-40 of 104) with videos related to
Sort By:
Pageof 11
Diagnosis (Berlin, Germany)|September 19, 2024
Vitamin D assay and supplementation: still debatable issuesMario Plebani, Martina Zaninotto, Sandro Giannini, et al.Journal of Clinical Medicine|October 13, 2021
Bone Biopsy for Histomorphometry in Chronic Kidney Disease (CKD): State-of-the-Art and New PerspectivesLuca Dalle Carbonare, Maria Teresa Valenti, Sandro Giannini, et al.Blood Pressure|April 21, 2011
Effect of olmesartan on oxidative stress in hypertensive patients: mechanistic support to clinical trials derived evidenceLorenzo A Cal, Lucia Dal Maso, Paola Caielli, et al.Drug Safety|May 15, 2013
Long-term proton pump inhibitor use is associated with vascular calcification in chronic kidney disease: a cross-sectional study using propensity score analysisMaria Fusaro, Marianna Noale, Giovanni Tripepi, et al.Plos One|August 5, 2015
Differential Effects of Dabigatran and Warfarin on Bone Volume and Structure in Rats with Normal Renal FunctionMaria Fusaro, Luca Dalle Carbonare, Adriana Dusso, et al.Cardiorenal Medicine|October 26, 2018
Chronic Hyperkalemia in Cardiorenal Patients: Risk Factors, Diagnosis, and New Treatment OptionsLuca Di Lullo, Claudio Ronco, Antonio Granata, et al.Nutrients|May 28, 2022
Alkaline Phosphatase: An Old Friend as Treatment Target for Cardiovascular and Mineral Bone Disorders in Chronic Kidney DiseaseMathias Haarhaus, Giuseppe Cianciolo, Simona Barbuto, et al.Clinical Kidney Journal|August 5, 2024
Vertebral fractures in patients with CKD and the general population: a call for diagnosis and actionLaia Gifre, Elisabet Massó, Maria Fusaro, et al.Journal of Nephrology|September 2, 2024
Native vitamin D in CKD and renal transplantation: meaning and rationale for its supplementationCarlo Alfieri, Paolo Molinari, Simone Vettoretti, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 24, 2013
SIRT1, heme oxygenase-1 and NO-mediated vasodilation in a human model of endogenous angiotensin II type 1 receptor antagonism: implications for hypertensionPaul A Davis, Elisa Pagnin, Lucia Dal Maso, et al.Pageof 11